Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
Recruiting · NCT02965326 · Registry updated 2024-03-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Not applicable | 2024-03-12 | NCT02965326 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Association Mucoviscidose-ABCF2 | 1 |
| Hôpital Necker-Enfants Malades | 15 |
| Vaincre la Mucoviscidose | 4 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Necker Hospital | Paris | France | 1 |